Company Filing History:
Years Active: 2021-2025
Title: Judith Peterschmitt: Innovator in Pharmaceutical Applications
Introduction
Judith Peterschmitt is a notable inventor based in Watertown, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit glucosylceramide synthase. Her work has implications for treating various diseases, showcasing her innovative spirit and dedication to advancing medical science.
Latest Patents
Judith Peterschmitt holds one patent titled "Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase." This patent discloses the hemitartrate salt of a compound represented by a specific structural formula. The invention may be utilized in pharmaceutical applications, and it details particular single crystalline forms characterized by various properties and physical measurements. Additionally, the patent discusses methods for producing crystalline Formula (I) Hemitartrate and its use in lowering glycosphingolipid concentrations in subjects to treat a number of diseases. Pharmaceutical compositions related to this invention are also described.
Career Highlights
Judith has been associated with Genzyme Corporation, where she has contributed her expertise in pharmaceutical research and development. Her work has been instrumental in advancing the understanding of glucosylceramide synthase inhibitors and their potential therapeutic applications.
Collaborations
Judith has collaborated with notable colleagues, including Hanlan Liu and Christopher Willis. Their combined efforts have furthered research in the pharmaceutical field, leading to innovative solutions for complex medical challenges.
Conclusion
Judith Peterschmitt's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her patent work and collaborations reflect her commitment to improving health outcomes through scientific advancements.